Skip to content

The effects of a test food on attenuating fatigue sensation

The effects of a test food on attenuating fatigue sensation - The effects of a test food on attenuating fatigue sensation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061083
Enrollment
200
Registered
2026-03-27
Start date
2026-05-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Intake of test food for 4 weeks Intake of a placebo for 4 weeks

Sponsors

NH Foods Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Males and females aged 20 years or more and less than 65 years 2)Persons having fatigue sensation in daily life 3)Persons with a BMI of 18.5 kg/m2 or more, and less than 25.0 kg/m2 4)Persons receiving sufficient briefing of the objective and content of the present study, fully understanding and agreeing to voluntarily participate in the study, and being able to personally sign a written informed consent

Exclusion criteria

Exclusion criteria: 1)Persons receiving medical treatment for serious cardio-vascular, hepatic, renal, respiratory, endocrine, or metabolic disorders or having a medical history of these disorders 2)Persons having been diagnosed with chronic fatigue syndrome or idiopathic chronic fatigue 3)Persons whose pure alcohol intake per day is 60 g or more 4)Persons who may develop allergic symptoms from consuming the test food 5)Persons whose lifestyles are irregular such as those who work a night shift 6)Persons planning an oversea trip during the study period 7)Persons regularly taking medicines or quasi-drug products that affect fatigue 8)Persons regularly taking "Food with Functional Claims" that affect fatigue sensation 9)Persons who are pregnant or lactating, or intending to become pregnant during the study period 10)Persons who took part in another clinical study within 3 months prior to the start of the present study or who are currently taking part in another clinical study 11)Persons deemed unsuitable by the investigator

Design outcomes

Primary

MeasureTime frame
VAS (fatigue sensation) daily upon waking

Secondary

MeasureTime frame
VAS (fatigue sensation) at the time of visit, Chalder fatigue scale

Countries

Japan

Contacts

Public ContactTomohiro Sugino

Soiken Inc. R&D Division

sugino@soiken.com06-6871-8888

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026